To test the cognitive effects of aging and apolipoprotein E (APOE) in individuals at high risk for Alzheimer's disease (AD), we assessed APOE genotypes and performance on a battery of neuropsychological tests in 41 non-demented, Down syndrome (DS) adults. Old DS subjects (ages 41-61 years) showed poorer memory and orientation scores than young DS adults (ages 22-38 years), but the groups did not differ in other measures after we controlled for intellectual function. Language ability was inversely related to APOE genotype, even after age was controlled for, with the presence of the epsilon 2 allele corresponding to better language skills than epsilon 4. Age-related cognitive changes in non-demented DS adults are consistent with the early eff...
IntroductionAdults with Down syndrome (DS) are at ultra-high risk of developing Alzheimer's disease ...
Apolipoprotein E (APOE) genotype is a possible influence on nonpathological cognitive aging. The aut...
Accurate identification of the prodromal stage of Alzheimer’s disease (AD), known as mild cognitive ...
To test the cognitive effects of aging and apolipoprotein E (APOE) in individuals at high risk for A...
BACKGROUND: Recent studies of the relationship between the apolipoprotein E (APOE) gene and Alzhei...
Apolipoprotein E (APOE) is consistently associated with dementia in the general population. Findings...
Item does not contain fulltextApolipoprotein E (APOE) is consistently associated with dementia in th...
textabstractThe prevalence of clinical signs and neuropathological findings of Alzheimer's disease (...
Poster exhibited at GPSC Student Showcase, November 7th, 2014, University of Arizona.Given the early...
Down syndrome (DS) might be considered a model for unsuccessful and early aging, possibly accelerate...
International audienceImportance: Alzheimer disease (AD) is the leading cause of death in individual...
Down syndrome (DS) might be considered a model for unsuccessful and early aging, possibly accelerate...
Down syndrome (DS) might be considered a model for unsuccessful and early aging, possibly accelerate...
Accurate identification of the prodromal stage of Alzheimer's disease (AD), known as mild cognitive ...
Genetic variation in the APOE gene and variation in chromosome 21 genotypes, including the APP locus...
IntroductionAdults with Down syndrome (DS) are at ultra-high risk of developing Alzheimer's disease ...
Apolipoprotein E (APOE) genotype is a possible influence on nonpathological cognitive aging. The aut...
Accurate identification of the prodromal stage of Alzheimer’s disease (AD), known as mild cognitive ...
To test the cognitive effects of aging and apolipoprotein E (APOE) in individuals at high risk for A...
BACKGROUND: Recent studies of the relationship between the apolipoprotein E (APOE) gene and Alzhei...
Apolipoprotein E (APOE) is consistently associated with dementia in the general population. Findings...
Item does not contain fulltextApolipoprotein E (APOE) is consistently associated with dementia in th...
textabstractThe prevalence of clinical signs and neuropathological findings of Alzheimer's disease (...
Poster exhibited at GPSC Student Showcase, November 7th, 2014, University of Arizona.Given the early...
Down syndrome (DS) might be considered a model for unsuccessful and early aging, possibly accelerate...
International audienceImportance: Alzheimer disease (AD) is the leading cause of death in individual...
Down syndrome (DS) might be considered a model for unsuccessful and early aging, possibly accelerate...
Down syndrome (DS) might be considered a model for unsuccessful and early aging, possibly accelerate...
Accurate identification of the prodromal stage of Alzheimer's disease (AD), known as mild cognitive ...
Genetic variation in the APOE gene and variation in chromosome 21 genotypes, including the APP locus...
IntroductionAdults with Down syndrome (DS) are at ultra-high risk of developing Alzheimer's disease ...
Apolipoprotein E (APOE) genotype is a possible influence on nonpathological cognitive aging. The aut...
Accurate identification of the prodromal stage of Alzheimer’s disease (AD), known as mild cognitive ...